SG72889A1 - Carbohydrate derivatives - Google Patents

Carbohydrate derivatives

Info

Publication number
SG72889A1
SG72889A1 SG1998004851A SG1998004851A SG72889A1 SG 72889 A1 SG72889 A1 SG 72889A1 SG 1998004851 A SG1998004851 A SG 1998004851A SG 1998004851 A SG1998004851 A SG 1998004851A SG 72889 A1 SG72889 A1 SG 72889A1
Authority
SG
Singapore
Prior art keywords
carbohydrate derivatives
carbohydrate
derivatives
Prior art date
Application number
SG1998004851A
Other languages
English (en)
Inventor
Van Constant Adriaan A Boeckel
Maurice Petitou
Philippe Duchaussoy
Johannes Egbertus Maria Basten
Cornelia Maria Dreef-Tromp
Original Assignee
Akzo Nobel Nv
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sanofi Sa filed Critical Akzo Nobel Nv
Publication of SG72889A1 publication Critical patent/SG72889A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SG1998004851A 1997-11-19 1998-11-18 Carbohydrate derivatives SG72889A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97203613 1997-11-19

Publications (1)

Publication Number Publication Date
SG72889A1 true SG72889A1 (en) 2000-05-23

Family

ID=8228942

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1998004851A SG72889A1 (en) 1997-11-19 1998-11-18 Carbohydrate derivatives

Country Status (34)

Country Link
US (1) US6174863B1 (zh)
EP (1) EP1032579B1 (zh)
JP (1) JP4364959B2 (zh)
KR (1) KR100518497B1 (zh)
CN (1) CN1177855C (zh)
AR (1) AR017640A1 (zh)
AT (1) ATE239030T1 (zh)
AU (1) AU746959B2 (zh)
BR (1) BRPI9804699B1 (zh)
CA (1) CA2253113C (zh)
CO (1) CO4990974A1 (zh)
CZ (1) CZ293639B6 (zh)
DE (1) DE69814140T2 (zh)
DK (1) DK1032579T3 (zh)
EE (1) EE04348B1 (zh)
ES (1) ES2198081T3 (zh)
HK (1) HK1028406A1 (zh)
HU (1) HU226685B1 (zh)
ID (1) ID21287A (zh)
IL (1) IL126893A (zh)
IS (1) IS2527B (zh)
NO (1) NO310723B1 (zh)
NZ (1) NZ332834A (zh)
PE (1) PE134799A1 (zh)
PL (1) PL188229B1 (zh)
PT (1) PT1032579E (zh)
RU (1) RU2210573C2 (zh)
SG (1) SG72889A1 (zh)
SK (1) SK284134B6 (zh)
TR (1) TR199802372A2 (zh)
TW (1) TW448180B (zh)
UA (1) UA49089C2 (zh)
WO (1) WO1999025720A1 (zh)
ZA (1) ZA9810559B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI289566B (en) * 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
AU2002243630A1 (en) 2001-01-23 2002-08-06 Massachusetts Institute Of Technology Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
EP2982668A3 (en) 2002-12-03 2016-04-13 Pharmacyclics LLC 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders
CN1317287C (zh) * 2003-04-18 2007-05-23 山东大学 一种多硫酸寡糖及其制备方法
CA2557989C (en) * 2004-03-04 2013-04-23 Progen Industries Limited Sulfated oligosaccharide derivatives
US8614314B2 (en) 2008-05-30 2013-12-24 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
EP2323605A4 (en) * 2008-09-10 2014-02-05 Syneron Medical Ltd TRANSDERMAL RELEASE OF OLIGOSACCHARIDES
WO2011014793A2 (en) 2009-07-31 2011-02-03 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
ES2560467T3 (es) 2011-06-17 2016-02-19 Carbomimetics Pentasacáridos sintéticos que tienen vida media corta y alta actividad
EP2578594A1 (en) 2011-10-04 2013-04-10 Sanofi Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction
US9873712B2 (en) * 2014-10-03 2018-01-23 Amphastar Pharmaceuticals, Inc. Method of purifying idraparinux sodium
CN109134554B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134553B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134555B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
WO2021043631A1 (en) 2019-09-02 2021-03-11 Hepoligo Solutions Aps Intermediates useful for preparing iduronic acid containing di- and polysaccharides
WO2021211441A1 (en) * 2020-04-13 2021-10-21 The Board Of Regents Of The University Of Oklahoma Modified sugar polymers with low anticoagulant activity and therapeutic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
DE69100275T2 (de) * 1990-04-23 1993-12-02 Akzo Nv Eine Trisaccharideinheit enthaltende Kohlenhydratderivate.
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
EE04348B1 (et) 2004-08-16
HU226685B1 (en) 2009-06-29
UA49089C2 (uk) 2002-09-16
KR19990045312A (ko) 1999-06-25
HU9802663D0 (en) 1999-01-28
NO310723B1 (no) 2001-08-20
WO1999025720A1 (en) 1999-05-27
PL329789A1 (en) 1999-05-24
PT1032579E (pt) 2003-08-29
HK1028406A1 (en) 2001-02-16
EP1032579A1 (en) 2000-09-06
JP4364959B2 (ja) 2009-11-18
HUP9802663A2 (hu) 1999-06-28
EE200000301A (et) 2001-12-17
IL126893A (en) 2003-05-29
DE69814140T2 (de) 2004-04-08
TR199802372A2 (xx) 1999-06-21
PL188229B1 (pl) 2004-12-31
CA2253113C (en) 2008-06-17
US6174863B1 (en) 2001-01-16
NO985365D0 (no) 1998-11-18
JPH11217394A (ja) 1999-08-10
IS5485A (is) 2000-05-09
IL126893A0 (en) 1999-09-22
CZ293639B6 (cs) 2004-06-16
CO4990974A1 (es) 2000-12-26
NO985365L (no) 1999-05-20
BRPI9804699B1 (pt) 2016-07-12
IS2527B (is) 2009-07-15
EP1032579B1 (en) 2003-05-02
ATE239030T1 (de) 2003-05-15
DE69814140D1 (de) 2003-06-05
PE134799A1 (es) 2000-01-07
HUP9802663A3 (en) 2000-04-28
RU2210573C2 (ru) 2003-08-20
ES2198081T3 (es) 2004-01-16
AU9324298A (en) 1999-06-17
SK7362000A3 (en) 2000-10-09
CN1177855C (zh) 2004-12-01
DK1032579T3 (da) 2003-08-25
ID21287A (id) 1999-05-20
BR9804699A (pt) 2000-12-26
CZ376198A3 (cs) 1999-06-16
SK284134B6 (sk) 2004-09-08
CN1222524A (zh) 1999-07-14
AU746959B2 (en) 2002-05-09
KR100518497B1 (ko) 2005-12-16
CA2253113A1 (en) 1999-05-19
TW448180B (en) 2001-08-01
AR017640A1 (es) 2001-09-12
ZA9810559B (en) 1999-05-15
NZ332834A (en) 2000-01-28

Similar Documents

Publication Publication Date Title
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
IL133904A0 (en) Pyridine derivatives
HUP9801168A3 (en) Triazinylaminostilbene derivatives
HUP0004282A3 (en) 2-halo-6-0-substituted ketolide derivatives
IL126893A0 (en) Carbohydrate derivatives
ZA973892B (en) Carbohydrate derivatives
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
GB9701427D0 (en) Gemcitabine derivatives
ZA983116B (en) Arylsecocholadiene derivatives
IL131159A0 (en) 4-Aminoethoxyindazole derivatives
GB2323842A8 (en) Pyridine derivatives
EG23813A (en) Carbohydrate derivatives
GB9706753D0 (en) Aralkoxy-morphinan derivatives
SI1005445T1 (en) N-alkanoylphenylalanine derivatives
GB9702505D0 (en) Amino-benzothiazole derivatives
GB9720329D0 (en) 4-cyano-4-deformylsordarin derivatives
ZA983700B (en) 1-galactose derivatives